n 0437, (-)-isomer has been researched along with Dyskinesia, Medication-Induced in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boroojerdi, B; Giladi, N; Surmann, E | 1 |
Jenner, P | 1 |
Kanaya, Y; Kono, R; Kuriyama, M; Shiga, Y; Shimoe, Y; Takeshima, S | 1 |
Gerlach, M; Gruenblatt, E; Heindl, M; Lebsanft, H; Mayerhofer, A; Riederer, P; Scheller, DK; Schmidt, WJ | 1 |
Iravani, MM; Jackson, MJ; Jenner, P; Olanow, CW; Rose, S; Scheller, D; Smith, LA; Stockwell, KA; Tayarani-Binazir, K | 1 |
Iravani, MM; Jackson, MJ; Jenner, P; Rose, S; Scheller, DK; Smith, LA; Stockwell, KA | 1 |
LeWitt, PA; Lyons, KE; Pahwa, R | 1 |
1 review(s) available for n 0437, (-)-isomer and Dyskinesia, Medication-Induced
Article | Year |
---|---|
Wearing off, dyskinesia, and the use of continuous drug delivery in Parkinson's disease.
Topics: Animals; Clinical Trials as Topic; Dopamine Agonists; Drug Delivery Systems; Dyskinesia, Drug-Induced; Humans; Parkinson Disease; Tetrahydronaphthalenes; Thiophenes; Treatment Outcome | 2013 |
2 trial(s) available for n 0437, (-)-isomer and Dyskinesia, Medication-Induced
Article | Year |
---|---|
The safety and tolerability of rotigotine transdermal system over a 6-year period in patients with early-stage Parkinson's disease.
Topics: Adolescent; Aged; Aged, 80 and over; Antiparkinson Agents; Double-Blind Method; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Electrocardiography; Female; Humans; Kaplan-Meier Estimate; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies; Survival Analysis; Tetrahydronaphthalenes; Thiophenes; Transdermal Patch; Treatment Outcome | 2013 |
Advanced Parkinson disease treated with rotigotine transdermal system: PREFER Study.
Topics: Administration, Cutaneous; Aged; Dopamine Agonists; Double-Blind Method; Drug Administration Routes; Drug Administration Schedule; Dyskinesia, Drug-Induced; Erythema; Female; Humans; Male; Middle Aged; Parkinson Disease; Placebos; Pruritus; Tetrahydronaphthalenes; Thiophenes; Time Factors; Treatment Outcome | 2007 |
4 other study(ies) available for n 0437, (-)-isomer and Dyskinesia, Medication-Induced
Article | Year |
---|---|
Dementia with Lewy bodies presenting marked tongue protrusion and bite due to lingual dystonia: A case report.
Topics: Acute Disease; Antipsychotic Agents; Benzodiazepines; Bites and Stings; Drug Interactions; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Indoles; Laryngeal Diseases; Levodopa; Lewy Body Disease; Middle Aged; Olanzapine; Receptors, Dopamine D1; Tetrahydronaphthalenes; Thiophenes; Tongue Diseases | 2016 |
Continuous versus pulsatile administration of rotigotine in 6-OHDA-lesioned rats: contralateral rotations and abnormal involuntary movements.
Topics: Adrenergic Agents; Animals; Dopamine Agonists; Dyskinesia, Drug-Induced; Dyskinesias; Male; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Rotation; Tetrahydronaphthalenes; Thiophenes | 2008 |
Continuous administration of rotigotine to MPTP-treated common marmosets enhances anti-parkinsonian activity and reduces dyskinesia induction.
Topics: Analysis of Variance; Animals; Antiparkinson Agents; Callithrix; Disease Models, Animal; Drug Administration Schedule; Drug Delivery Systems; Dyskinesia, Drug-Induced; Female; Levodopa; Male; Motor Activity; Motor Skills; MPTP Poisoning; Tetrahydronaphthalenes; Thiophenes | 2009 |
Continuous rotigotine administration reduces dyskinesia resulting from pulsatile treatment with rotigotine or L-DOPA in MPTP-treated common marmosets.
Topics: Animals; Callithrix; Disability Evaluation; Disease Models, Animal; Dopamine Agents; Drug Administration Schedule; Drug Delivery Systems; Dyskinesia, Drug-Induced; Female; Levodopa; Male; Motor Activity; MPTP Poisoning; Statistics, Nonparametric; Tetrahydronaphthalenes; Thiophenes; Time Factors | 2010 |